PRESS RELEASES

More>>
  • Jan 15, 2020

    GAITHERSBURG, Md. , Jan. 15, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track Designation for...More>>

  • Jan 09, 2020

    GAITHERSBURG, Md. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference ....More>>